Skip to content
PulseMS
Back to feed
AI CuratorAI-generated
Research summary ·
AI summary · not yet reviewedSubjects not reportedSystematic reviewPeer review unconfirmed

Microfold Cells and MAP: Insights from Systematic Review

A systematic review found that Mycobacterium avium subspecies paratuberculosis (MAP) may play a role in Crohn's disease. However, links to multiple sclerosis, type 1 diabetes, and amyotrophic lateral sclerosis were noted as associative only, with no proven causation. MAP is capable of invading intestinal microfold cells, suggesting a potential mechanism for its persistence in the body.

Most relevant to
—
This plain-English summary was written by AI from a published abstract and may contain errors. It is not medical advice. Read the original study and talk to your MS team before making decisions about treatment.

Why it matters

Understanding the association between MAP and these diseases could reveal insights into their pathogenic mechanisms, though it does not establish a direct cause.

What this does not prove

Key limitations include the inability of PCR to differentiate between live and dead organisms, complicating investigations into MAP's roles in these diseases.

Next milestone

No next milestone was established from the available source.

Study facts
Study design
Systematic review
Participants / samples
Not reported
Randomised
Not reported
Controlled
Not reported
Primary endpoint met
Not reported
Relevant MS type
Not reported
Publication date
2026-09-15
Evidence reviewed
Abstract only
Regulatory approval
Not reported
Research areas
Not classified

Original sources

Supporting passages (6)
study designThis narrative review synthesizes MAP environmental distribution, strain genotyping, transmission routes, and multistage pathogenic mechanisms.
findingsCumulative epidemiological and molecular evidence implies MAP may contribute to Crohn's disease (CD), whereas its links to multiple sclerosis (MS), type 1 diabetes mellitus (T1DM), and amyotrophic lateral sclerosis (ALS) remain associative without proven causality.
findingsCumulative epidemiological and molecular evidence implies MAP may contribute to Crohn's disease (CD), whereas its links to multiple sclerosis (MS), type 1 diabetes mellitus (T1DM), and amyotrophic lateral sclerosis (ALS) remain associative without proven causality.
findingsMAP breaches the intestinal barrier via fibronectin attachment protein (FAP)-mediated invasion of microfold cells and establishes intracellular persistence within macrophages.
limitationsWe also critically assess diagnostic limitations-particularly the inability of polymerase chain reaction (PCR) to distinguish viable from non-viable organisms-and highlight major research challenges, including extrapolation of virulence mechanisms from other mycobacterial species.
publication datePublication date: 2026-09-15

AI assessment, not yet reviewed by a person · version 1 · Community votes are separate from evidence review.

0

Discussion 0 comments

Log in or join to comment.